AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 JAN 1 - (NewsRx.com & NewsRx.net) -- "News of a vaccine that can combat the type of human papillomavirus (HPV) that causes most cervical cancer is very hopeful, but also points out how prevalent and dangerous this sexually transmitted disease is," said Joe S. McIlhaney, Jr., president of the Medical Institute for Sexual Health.
"HPV is the most common viral STD. A recent major study of sexually active women ages 18 through 22 found that 50% were infected with HPV. It is the cause of almost all cervical dysplasia, which is the precancerous change of the cervix, and of 93% of all cervical cancer. It is estimated that 4100 women died as a result of cervical cancer in the United States in 2001, more than the number of women who died of AIDS that same year.
"We are hopeful that this vaccine leads to eradicating the threat of HPV but that is still several years away at best. Longer term follow up is still necessary to establish that the vaccine is safe and to determine how long the protection may last. And, since HPV 16 - the type ...
Source: HighBeam Research, HPV vaccine offers hope.